Healthpeak Properties stock has risen 12.5% over the past three months, outpacing the State Street Real Estate Select Sector SPDR ETF's 4.4% gain. On a year-to-date basis, DOC is up 21.6% compared to XLRE's 12.1% increase, and over the past 52 weeks it has returned 14.7% versus the ETF's nearly 8%. The shares surged 18.1% after first-quarter 2026 results beat expectations, with adjusted FFO of $0.45 per share and revenue of $753 million, and the company raised its full-year 2026 adjusted FFO guidance to $1.71 to $1.75 per share. Rival Welltower has lagged on a year-to-date basis with an 11.3% return but has soared 34.9% over the past 52 weeks, exceeding DOC's performance. Analysts maintain a consensus Moderate Buy rating on Healthpeak Properties with a mean price target of $21.12, representing a premium of nearly 8% to current levels.
Healthpeak Properties IncQ1 2026 earnings beat expectations and full-year FFO guidance raised.
Welltower Inc